Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
141.96
Dollar change
+0.97
Percentage change
0.69
%
Index- P/E49.02 EPS (ttm)2.90 Insider Own0.02% Shs Outstand3.38B Perf Week-0.37%
Market Cap473.92B Forward P/E33.96 EPS next Y4.18 Insider Trans0.00% Shs Float3.34B Perf Month5.03%
Income12.98B PEG17.51 EPS next Q0.80 Inst Own9.73% Short Float0.13% Perf Quarter9.34%
Sales35.52B P/S13.34 EPS this Y25.83% Inst Trans-2.75% Short Ratio1.20 Perf Half Y41.97%
Book/sh3.21 P/B44.19 EPS next Y22.43% ROA32.56% Short Interest4.48M Perf Year76.85%
Cash/sh0.40 P/C351.84 EPS next 5Y2.80% ROE99.99% 52W Range75.56 - 144.50 Perf YTD37.23%
Dividend Est.1.63 (1.15%) P/FCF51.03 EPS past 5Y16.48% ROI77.53% 52W High-1.76% Beta0.41
Dividend TTM1.81 (1.27%) Quick Ratio0.50 Sales past 5Y14.25% Gross Margin84.65% 52W Low87.88% ATR (14)2.40
Dividend Ex-DateMar 22, 2024 Current Ratio0.70 EPS Y/Y TTM52.89% Oper. Margin45.00% RSI (14)63.01 Volatility1.30% 1.54%
Employees63370 Debt/Eq0.27 Sales Y/Y TTM34.74% Profit Margin36.56% Recom1.88 Target Price140.81
Option/ShortYes / Yes LT Debt/Eq0.17 EPS Q/Q30.72% Payout36.03% Rel Volume0.81 Prev Close140.99
Sales Surprise2.61% EPS Surprise8.33% Sales Q/Q23.66% EarningsMay 02 BMO Avg Volume3.73M Price141.96
SMA202.20% SMA507.49% SMA20024.68% Trades Volume3,028,929 Change0.69%
Date Action Analyst Rating Change Price Target Change
May-30-24Initiated Goldman Buy $156
Apr-12-24Initiated BMO Capital Markets Outperform $163
Jan-23-24Initiated Morgan Stanley Overweight $120
Jan-16-24Resumed UBS Neutral
Dec-01-23Initiated Cantor Fitzgerald Overweight $120
Oct-02-23Initiated Argus Buy $110
Jul-14-23Initiated HSBC Securities Buy
Jul-15-22Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-28-22Downgrade UBS Neutral → Sell
Jun-27-22Upgrade Exane BNP Paribas Underperform → Neutral
Jun-23-24 01:01AM
Jun-21-24 02:00PM
10:13AM
09:53AM
08:30AM
05:00AM Loading…
05:00AM
Jun-20-24 05:45PM
02:51PM
02:07PM
01:38PM
Jun-19-24 06:45AM
Jun-18-24 03:51PM
03:51PM
01:11PM
11:04AM
09:30AM Loading…
09:30AM
08:00AM
Jun-17-24 01:01PM
09:53AM
09:50AM
08:26AM
07:04AM
06:00AM
Jun-15-24 06:50AM
Jun-14-24 05:45PM
05:40PM
04:08PM
03:58PM
02:48PM
12:34PM
11:58AM Loading…
11:58AM
09:30AM
08:02AM
07:15AM
06:37AM
06:15AM
05:50AM
Jun-12-24 02:03PM
01:50PM
12:26PM
10:37AM
08:00AM
Jun-11-24 02:30PM
01:13PM
10:54AM
09:13AM
06:00AM
04:57AM
Jun-10-24 04:38PM
02:32PM
09:00AM
08:15AM
06:00AM
Jun-09-24 08:59AM
07:30AM
Jun-08-24 09:00AM
07:40AM
Jun-07-24 02:00PM
Jun-06-24 10:53PM
05:23PM
05:10PM
02:47PM
07:00AM
05:25AM
02:18AM
Jun-05-24 07:06PM
05:37PM
04:00PM
01:59PM
11:17AM
08:01AM
Jun-04-24 03:12PM
01:07PM
10:35AM
09:53AM
Jun-03-24 01:17PM
10:05AM
10:00AM
Jun-02-24 09:30AM
08:25AM
Jun-01-24 10:25AM
08:00AM
05:05AM
05:05AM
May-31-24 04:18PM
01:20PM
10:03AM
06:00AM
05:23AM
May-30-24 05:41PM
08:30AM
04:39AM
May-29-24 10:06AM
06:00AM
May-28-24 05:56PM
03:11PM
03:11PM
01:59PM
12:48PM
11:32AM
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.